Discover reviews, ratings, and trailers for The Book of Eli on Rotten Tomatoes. Stay updated with critic and audience scores today!

The Irish outfit spoke to Radio X's Sunta Templeton after their Glastonbury 2025 set and revealed whether they'll be catching the Manchester band's much-anticipated reunion dates.

McCartney himself headlined Glastonbury back in 2022, with his set receiving a glowing five-star review from NME. “Bowing out after a [Dave] Grohl and [Bruce] Springsteen-assisted ‘Abbey Road’ medley, ...

Dublin band Inhaler deliver a soaring set at The Other Stage at Glastonbury Festival, during which they dedicate a song to ...

Bono returns to Billboard’s Hot R&B/Hip-Hop Songs chart for the first time in 25 years on Lil Wayne’s “The Days,” which debuts at No. 29.

Boston Globe via Getty Images Eli Lilly’s $1.3 billion acquisition of Verve Therapeutics represents a strategic move into cardiovascular genetic medicine.

Eli Lilly (LLY -2.40%) has been one of the hottest healthcare stocks to own in recent years, thanks in large part to the success of its incredibly successful GLP-1 agonist drugs, which help ...

UBS analyst Trung Huynh reiterated a Buy rating on Eli Lilly stock with a $1,050.00 price target, describing the acquisition as a sensible "bolt on" for the pharmaceutical giant.

Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing ...

Notre Dame football players Jaden Greathouse and Eli Raridon threw out the first pitch at a South Bend Cubs game. The list of Notre Dame football players getting the opportunity to throw out the first ...

Eli Lilly will acquire Verve for roughly $1 billion Verve is developing a one-time gene-editing treatment for heart disease The company's lead drug, Verve-102, targets a gene linked to high ...

Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.